Seeking Alpha

This afternoon's spike in shares of Complete Genomics (GNOM +7.1%) may be attributable to...

This afternoon's spike in shares of Complete Genomics (GNOM +7.1%) may be attributable to remarks by CEO Cliff Reid on a recent paper that finds GNOM's whole genome sequencing service more accurate than Illumina's (ILMN +0.7%) HiSeq 2000 instrument. Reid says GNOM's sequencing produces 1/50th as many errors as ILMN's.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector